Skip to main content
. 2022 Oct 13;11(20):6046. doi: 10.3390/jcm11206046

Table 3.

Clinical profile of the investigated sample.

DM Group 1
(Control)
Group 2
(CVR)
Group 3
(CVD)
Total χ2, p
n % n % n % n %
No 102 100 94 42.3 49 58.3 245 60 χ2 = 96.977
p = 0.000
Yes 0 0 128 57.7 35 41.7 163 40
χ2, p-value for association of DM with Gr. 2 and 3: χ2 = 6.260, p = 0.012
HTN
No 102 100 94 42.3 26 31 222 54.4 χ2 = 117.133
p = 0.000
Yes 0 0 128 57.7 58 69 186 45.6
χ2, p-value for association of HTN with Gr. 2 and 3: χ2 = 3.317, p = 0.069
Dyslipidemia
No 102 100 217 97.7 45 53.6 364 89.2 χ2 = 140.050
p = 0.000
Yes 0 0 5 2.3 39 46.4 44 10.8
χ2, p-value for association of dyslipidemia with Gr. 2 and 3: χ2 = 96.600, p = 0.000
Smoking
No 102 100 191 86 76 90.5 369 90.4 χ2 = 15.764
p = 0.000
Yes 0 0 31 14 8 9.5 39 9.6
χ2, p-value for association of smoking with Gr. 2 and 3: χ2 = 1.080, p = 0.299
Total 102 100 222 100 84 100 408 100